Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020. Issue 3 (9th August 2022)
- Record Type:
- Journal Article
- Title:
- Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020. Issue 3 (9th August 2022)
- Main Title:
- Amphetamine‐related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020
- Authors:
- Perello, Rafael
Losada, Aelajandra
Chen Qin, Jiwei
Supervia, August
Salgado, Emilio
Smithson, Alex
Xipell, Marc
Inciarte, Alexis
Vallecillo, Gabriel - Abstract:
- Abstract: Background: Stimulant drugs, particularly amphetamines, are more commonly implicated in drug‐related deaths in people living with HIV; however, the clinical characteristics of amphetamine‐related intoxication in people living with HIV are poorly described. Material and methods: We conducted a retrospective study in people living with HIV who were admitted for amphetamine‐related intoxication to an emergency department of a teaching hospital between 2018 and 2021. Severe intoxication (SI) was arbitrarily defined as requiring admission to the emergency medical support unit and receiving medical treatment for ≥6 h. Results: In total, 170 male patients with a median age of 36.2 + 7.5 years were included in the study. A total of 77 (45.3%) individuals had mental disorders, and 120 (85.7%) had HIV‐1 RNA suppression, with a median CD4 cell count of 696 (interquartile range 490–905). In total, 61 (37.9%) individuals were on ritonavir/cobicistat‐based regimens. Presenting clinical syndromes included agitation in 60 (35.3%) subjects, anxiety in 37 (21.7%), psychosis in 27 (15.8%), chest pain in 26 (15.3%) and altered level of consciousness in 20 (11.7%). SI was observed in 48 (28.2%) individuals, 12 (7.1%) required admission to the intensive care unit, and two (1.2%) died. Altered level of consciousness (odds ratio [OR] 6.5; 95% confidence interval [CI] 2.2–18.9; p < 0.01), psychosis (OR 5.8; 95% CI 2.2–15.1; p < 0.01) and suicide attempt (OR 4.6; 95% CI 1.8–11.6; p 0.01)Abstract: Background: Stimulant drugs, particularly amphetamines, are more commonly implicated in drug‐related deaths in people living with HIV; however, the clinical characteristics of amphetamine‐related intoxication in people living with HIV are poorly described. Material and methods: We conducted a retrospective study in people living with HIV who were admitted for amphetamine‐related intoxication to an emergency department of a teaching hospital between 2018 and 2021. Severe intoxication (SI) was arbitrarily defined as requiring admission to the emergency medical support unit and receiving medical treatment for ≥6 h. Results: In total, 170 male patients with a median age of 36.2 + 7.5 years were included in the study. A total of 77 (45.3%) individuals had mental disorders, and 120 (85.7%) had HIV‐1 RNA suppression, with a median CD4 cell count of 696 (interquartile range 490–905). In total, 61 (37.9%) individuals were on ritonavir/cobicistat‐based regimens. Presenting clinical syndromes included agitation in 60 (35.3%) subjects, anxiety in 37 (21.7%), psychosis in 27 (15.8%), chest pain in 26 (15.3%) and altered level of consciousness in 20 (11.7%). SI was observed in 48 (28.2%) individuals, 12 (7.1%) required admission to the intensive care unit, and two (1.2%) died. Altered level of consciousness (odds ratio [OR] 6.5; 95% confidence interval [CI] 2.2–18.9; p < 0.01), psychosis (OR 5.8; 95% CI 2.2–15.1; p < 0.01) and suicide attempt (OR 4.6; 95% CI 1.8–11.6; p 0.01) were associated with SI in the adjusted analysis. Conclusions: Amphetamine‐related intoxication causes high morbidity in people living with HIV. Healthcare providers serving these patients should consider incorporating harm‐reduction measures in the prevention of amphetamine‐related intoxication. … (more)
- Is Part Of:
- HIV medicine. Volume 24:Issue 3(2023)
- Journal:
- HIV medicine
- Issue:
- Volume 24:Issue 3(2023)
- Issue Display:
- Volume 24, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 24
- Issue:
- 3
- Issue Sort Value:
- 2023-0024-0003-0000
- Page Start:
- 260
- Page End:
- 266
- Publication Date:
- 2022-08-09
- Subjects:
- amphetamine -- emergency -- HIV
HIV infections -- Treatment -- Periodicals
HIV-positive persons -- Periodicals
HIV infections -- Treatment -- Decision making -- Periodicals
616.9792 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=hiv ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-1293 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hiv.13365 ↗
- Languages:
- English
- ISSNs:
- 1464-2662
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4319.045900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26305.xml